195 related articles for article (PubMed ID: 29208599)
1. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study.
Lindahl LM; Besenbacher S; Rittig AH; Celis P; Willerslev-Olsen A; Gjerdrum LMR; Krejsgaard T; Johansen C; Litman T; Woetmann A; Odum N; Iversen L
Blood; 2018 Feb; 131(7):759-770. PubMed ID: 29208599
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
3. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients.
Talaat IM; Abdelmaksoud RE; Guimei M; Agamia NF; Nugud A; El-Serafi AT
PLoS One; 2019; 14(10):e0224305. PubMed ID: 31648231
[TBL] [Abstract][Full Text] [Related]
4. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
6. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.
de Masson A; O'Malley JT; Elco CP; Garcia SS; Divito SJ; Lowry EL; Tawa M; Fisher DC; Devlin PM; Teague JE; Leboeuf NR; Kirsch IR; Robins H; Clark RA; Kupper TS
Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743350
[TBL] [Abstract][Full Text] [Related]
7. Aberrant microRNA expression in tumor mycosis fungoides.
Papadavid E; Braoudaki M; Bourdakou M; Lykoudi A; Nikolaou V; Tounta G; Ekonomidi A; Athanasiadis E; Spyrou G; Antoniou C; Kitsiou-Tzeli S; Rigopoulos D; Kolialexi A
Tumour Biol; 2016 Nov; 37(11):14667-14675. PubMed ID: 27623940
[TBL] [Abstract][Full Text] [Related]
8. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
9. Altered microRNA expression in folliculotropic and transformed mycosis fungoides.
Marosvári D; Téglási V; Csala I; Marschalkó M; Bödör C; Timár B; Csomor J; Hársing J; Reiniger L
Pathol Oncol Res; 2015 Jul; 21(3):821-5. PubMed ID: 25698383
[TBL] [Abstract][Full Text] [Related]
10. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides.
Lindahl LM; Gluud M; Emmanuel T; Thomsen EA; Hu T; Rittig AH; Celis P; Stolearenco V; Krejsgaard T; Johansen C; Willerslev-Olsen A; Buus TB; Woetmann A; Aagaard L; Geisler C; Litman T; Mikkelsen JG; Odum N; Iversen L
Acta Derm Venereol; 2020 Sep; 100(16):adv00270. PubMed ID: 32556351
[TBL] [Abstract][Full Text] [Related]
12. miRNA expression profiling of mycosis fungoides.
van Kester MS; Ballabio E; Benner MF; Chen XH; Saunders NJ; van der Fits L; van Doorn R; Vermeer MH; Willemze R; Tensen CP; Lawrie CH
Mol Oncol; 2011 Jun; 5(3):273-80. PubMed ID: 21406335
[TBL] [Abstract][Full Text] [Related]
13. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
14. Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management.
Wu JH; Cohen BA; Sweren RJ
Pediatr Dermatol; 2020 Jan; 37(1):18-28. PubMed ID: 31630432
[TBL] [Abstract][Full Text] [Related]
15. Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation.
Rittig AH; Johansen C; Celis P; Odum N; Litman T; Woetmann A; Lindahl LM; Iversen L
Exp Dermatol; 2021 Aug; 30(8):1141-1149. PubMed ID: 32492224
[TBL] [Abstract][Full Text] [Related]
16. Updated review on prognostic factors in mycosis fungoides and new skin lymphoma trials.
Farabi B; Seminario-Vidal L; Jamgochian M; Akay BN; Atak MF; Rao BK; Karagaiah P; Grabbe S; Goldust M
J Cosmet Dermatol; 2022 Jul; 21(7):2742-2748. PubMed ID: 34687485
[TBL] [Abstract][Full Text] [Related]
17. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.
Lebowitz E; Geller S; Flores E; Pulitzer M; Horwitz S; Moskowitz A; Kheterpal M; Myskowski PL
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):108-114. PubMed ID: 30176169
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
[TBL] [Abstract][Full Text] [Related]
19. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
Scarisbrick JJ; Quaglino P; Prince HM; Papadavid E; Hodak E; Bagot M; Servitje O; Berti E; Ortiz-Romero P; Stadler R; Patsatsi A; Knobler R; Guenova E; Child F; Whittaker S; Nikolaou V; Tomasini C; Amitay I; Prag Naveh H; Ram-Wolff C; Battistella M; Alberti-Violetti S; Stranzenbach R; Gargallo V; Muniesa C; Koletsa T; Jonak C; Porkert S; Mitteldorf C; Estrach T; Combalia A; Marschalko M; Csomor J; Szepesi A; Cozzio A; Dummer R; Pimpinelli N; Grandi V; Beylot-Barry M; Pham-Ledard A; Wobser M; Geissinger E; Wehkamp U; Weichenthal M; Cowan R; Parry E; Harris J; Wachsmuth R; Turner D; Bates A; Healy E; Trautinger F; Latzka J; Yoo J; Vydianath B; Amel-Kashipaz R; Marinos L; Oikonomidi A; Stratigos A; Vignon-Pennamen MD; Battistella M; Climent F; Gonzalez-Barca E; Georgiou E; Senetta R; Zinzani P; Vakeva L; Ranki A; Busschots AM; Hauben E; Bervoets A; Woei-A-Jin FJSH; Matin R; Collins G; Weatherhead S; Frew J; Bayne M; Dunnill G; McKay P; Arumainathan A; Azurdia R; Benstead K; Twigger R; Rieger K; Brown R; Sanches JA; Miyashiro D; Akilov O; McCann S; Sahi H; Damasco FM; Querfeld C; Folkes A; Bur C; Klemke CD; Enz P; Pujol R; Quint K; Geskin L; Hong E; Evison F; Vermeer M; Cerroni L; Kempf W; Kim Y; Willemze R
Br J Dermatol; 2019 Aug; 181(2):350-357. PubMed ID: 30267549
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides.
Porkert S; Griss J; Hudelist-Venz M; Steiner I; Valencak J; Weninger W; Brunner PM; Jonak C
J Dtsch Dermatol Ges; 2024 Apr; 22(4):532-550. PubMed ID: 38444271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]